Lakefront Biotherapeutics NV (LKFT)

NASDAQ: LKFT · Real-Time Price · USD

28.80

+0.53 (1.87%)

At close: Aug 21, 2026, 4:00 PM EDT

28.78

-0.02 (-0.07%)

After-hours: Aug 21, 2026, 7:30 PM EDT

LKFT Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	990.57	1,112	275.65	239.72	241.25	234.38
Revenue Growth	259.41%	303.50%	14.99%	-0.63%	2.93%	-50.97%
Gross Profit	669.75	623.09	-94.67	-1.57	-28.55	-86.12
Operating Income	569.5	535.28	-187.1	-85.11	-131.06	-171.57
Net Income	596.64	320.88	74.08	211.7	-217.99	-103.23
Earnings Per Share	9.05	4.87	1.12	3.21	-3.32	-1.58
EPS Growth	-	333.66%	-65.05%	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States of America	1,081	240.79	239.71	241.15	234.34
Europe	31.1	34.86	0.02	0.1	0.04
Total	1,112	275.65	239.72	241.25	234.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,240	2,998	3,118	3,685	4,094	4,703
Total Debt	6.36	6.92	11.72	9.6	21.9	26.86
Net Cash (Debt)	2,233	2,991	3,106	3,675	4,072	4,676
Net Cash Growth	-27.57%	-3.69%	-15.48%	-9.75%	-12.92%	-8.88%
Net Cash Per Share	33.87	45.39	47.10	55.74	61.98	71.39

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-226.91	-257.46	-320.03	-405.97	-500.54	-503.83
Capital Expenditures	-4.61	-13.7	-16.72	-18.71	-27.39	-54.21
Free Cash Flow	-231.52	-271.16	-336.75	-424.68	-527.93	-558.03
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	67.61%	56.02%	-34.34%	-0.66%	-11.83%	-36.74%
Operating Margin	57.49%	48.13%	-67.87%	-35.50%	-54.32%	-73.20%
Pretax Margin	58.31%	27.05%	-1.12%	2.35%	-29.37%	-50.94%
Profit Margin	60.23%	28.85%	26.88%	88.31%	-90.36%	-44.04%
FCF Margin	-23.37%	-24.38%	-122.16%	-177.15%	-218.83%	-238.09%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.77	5.75	23.59	11.51	-	-
PS Ratio	1.67	1.66	6.34	10.17	11.28	13.77